CytoDyn Inc. (CYDY) stock
CYDYOTCPharmaceutical PreparationsFiscal year ends May 31
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Aug 31, 2026Last filing: 10-Q on Oct 14, 2026Score 4/30
$0.25+0.02 (+9.53%)
Close on Oct 19, 2026Market cap $345.56MP/E –Yield –
CytoDyn total assets
Total assets on the balance sheet at the end of each period.
CytoDyn's total assets was $19.05M at Aug 31, 2026. For fiscal 2026 it was $13.97M, down 22.6% from the year before. Over ten years it grew 0.1% a year on average. The highest annual figure on record is $132.08M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | May 31, 2026 | $13.97M | -22.6% |
| FY2025 | May 31, 2025 | $18.05M | +62.1% |
| FY2024 | May 31, 2024 | $11.14M | -1.4% |
| FY2023 | May 31, 2023 | $11.29M | -61.3% |
| FY2022 | May 31, 2022 | $29.19M | -77.9% |
| FY2021 | May 31, 2021 | $132.08M | +161.5% |
| FY2020 | May 31, 2020 | $50.51M | +142.0% |
| FY2019 | May 31, 2019 | $20.87M | +326.1% |
| FY2018 | May 31, 2018 | $4.90M | -39.2% |
| FY2017 | May 31, 2017 | $8.06M | -41.6% |
| FY2016 | May 31, 2016 | $13.79M | +194.6% |
| FY2015 | May 31, 2015 | $4.68M | -44.5% |
| FY2014 | May 31, 2014 | $8.43M | +102.7% |
| FY2013 | May 31, 2013 | $4.16M | +288.3% |
| FY2012 | May 31, 2012 | $1.07M | -46.3% |
| FY2011 | May 31, 2011 | $1.99M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ3 2026 | Aug 31, 2026 | $19.05M | +41.3% |
| Q4 FY2026CQ2 2026 | May 31, 2026 | $13.97M | -22.6% |
| Q3 FY2026CQ1 2026 | Feb 28, 2026 | $18.50M | -12.7% |
| Q2 FY2026CQ4 2025 | Nov 30, 2025 | $8.94M | -64.1% |
| Q1 FY2026CQ3 2025 | Aug 31, 2025 | $13.48M | -51.9% |
| Q4 FY2025CQ2 2025 | May 31, 2025 | $18.05M | +62.1% |
| Q3 FY2025CQ1 2025 | Feb 28, 2025 | $21.19M | +106.3% |
| Q2 FY2025CQ4 2024 | Nov 30, 2024 | $24.88M | +169.2% |
| Q1 FY2025CQ3 2024 | Aug 31, 2024 | $28.02M | +125.8% |
| Q4 FY2024CQ2 2024 | May 31, 2024 | $11.14M | -1.4% |
| Q3 FY2024CQ1 2024 | Feb 29, 2024 | $10.27M | +45.2% |
| Q2 FY2024CQ4 2023 | Nov 30, 2023 | $9.24M | -67.5% |
| Q1 FY2024CQ3 2023 | Aug 31, 2023 | $12.41M | -57.5% |
| Q4 FY2023CQ2 2023 | May 31, 2023 | $11.29M | -88.0% |
| Q2 FY2023CQ4 2022 | Nov 30, 2022 | $7.07M | -93.2% |
| Q1 FY2023CQ3 2022 | Aug 31, 2022 | $28.39M | -73.0% |
| Q4 FY2022CQ2 2022 | May 31, 2022 | $29.19M | -77.9% |
| Q3 FY2022CQ1 2022 | Feb 28, 2022 | $94.08M | -17.2% |
| Q2 FY2022CQ4 2021 | Nov 30, 2021 | $103.70M | -27.9% |
| Q1 FY2022CQ3 2021 | Aug 31, 2021 | $104.97M | +12.4% |
| Q4 FY2021CQ2 2021 | May 31, 2021 | $132.08M | +161.5% |
| Q3 FY2021CQ1 2021 | Feb 28, 2021 | $113.65M | +192.8% |
| Q2 FY2021CQ4 2020 | Nov 30, 2020 | $143.76M | +702.4% |
| Q1 FY2021CQ3 2020 | Aug 31, 2020 | $93.36M | +407.8% |
| Q4 FY2020CQ2 2020 | May 31, 2020 | $50.51M | +142.0% |
| Q3 FY2020CQ1 2020 | Feb 29, 2020 | $38.82M | +90.0% |
| Q2 FY2020CQ4 2019 | Nov 30, 2019 | $17.92M | -12.1% |
| Q1 FY2020CQ3 2019 | Aug 31, 2019 | $18.39M | +103.6% |
| Q4 FY2019CQ2 2019 | May 31, 2019 | $20.87M | +326.1% |
| Q3 FY2019CQ1 2019 | Feb 28, 2019 | $20.43M | +146.6% |
| Q2 FY2019CQ4 2018 | Nov 30, 2018 | $20.39M | +214.2% |
| Q1 FY2019CQ3 2018 | Aug 31, 2018 | $9.03M | +47.4% |
| Q4 FY2018CQ2 2018 | May 31, 2018 | $4.90M | -39.2% |
| Q3 FY2018CQ1 2018 | Feb 28, 2018 | $8.28M | -43.9% |
| Q2 FY2018CQ4 2017 | Nov 30, 2017 | $6.49M | -58.6% |
| Q1 FY2018CQ3 2017 | Aug 31, 2017 | $6.13M | -34.1% |
| Q4 FY2017CQ2 2017 | May 31, 2017 | $8.06M | – |
| Q3 FY2017CQ1 2017 | Feb 28, 2017 | $14.76M | – |
| Q2 FY2017CQ4 2016 | Nov 30, 2016 | $15.67M | – |
| Q1 FY2017CQ3 2016 | Aug 31, 2016 | $9.29M | – |
See a number that looks wrong?